Crossmark

Evaluation of an educational program for community pharmacists involved in pharmacotherapy for patients with impaired renal function: a preliminary study

Crossref DOI link: https://doi.org/10.1007/s10157-025-02698-5

Published Online: 2025-06-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Inoue, Akio

Kondo, Yuki https://orcid.org/0000-0003-1456-7721
Kondo, Tomoko

Ishitsuka, Yoichi
Funding

Funding for this research was provided by:

Japan Pharmaceutical Association
License Information

Text and Data Mining valid from 2025-06-03

Version of Record valid from 2025-06-03
More Information

Article History

Received: 16 October 2024

Accepted: 10 May 2025

First Online: 3 June 2025

Declarations

:

: The study was supported by a research grant received from the Japan Pharmaceutical Association. YI reports having patents or royalties with the Safety Medical System Laboratory Corporation. YK reports receiving research funding from Safety Medical System Laboratory Corporation; having patents or royalties with Safety Medical System Laboratory Corporation; and serving in an advisory or leadership role for Safety Medical System Laboratory Corporation (unpaid). The remaining authors have nothing to disclose.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number 2489) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below